EP3169403
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.7.2015EP published:
14.2.2024EP application number:
15821351.2
EPO information:
European Patent Register
Max expiry date:
14.7.2035
Title in English:
ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASESLanguage of the patent:
English
Timeline
Today
15.7.2015EP application
14.2.2024EP Publication
Owner
Name:
Protagonist Therapeutics, Inc.Address:
7707 Gateway Boulevard, Suite 140, Newark, CA 94560-1160, US
Inventor
Name:
BOURNE, GregoryAddress:
Jindalee, Queensland 4074, AU
Name:
BHANDARI, AshokAddress:
Pleasanton, California 94588, US
Name:
CHENG, XiaoLiAddress:
Mountain View, California 94043, US
Name:
FREDERICK, Brian TroyAddress:
Ben Lomand, California 98005, US
Name:
ZHANG, JieAddress:
Salisbury, Queensland 4107, AU
Name:
PATEL, Dinesh V.Address:
Fremont, California 94539, US
Name:
LIU, DavidAddress:
Palo Alto, California 94306, US
Priority
Number:
201462025899 PDate:
17.7.2014Country:
US
Number:
201562119688 PDate:
23.2.2015Country:
US
Number:
201562119685 PDate:
23.2.2015Country:
US
Classification
Categories:
C07K 14/54, A61P 1/00, A61P 1/04, A61P 1/16, A61P 1/18, A61P 3/10, A61P 5/48, A61P 11/00, A61P 11/02, A61P 11/06, A61P 15/14, A61P 17/06, A61P 19/02, A61P 35/00, A61P 37/06, A61P 43/00, A61K 38/00